Patents by Inventor Hanno Wild

Hanno Wild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Raf kinase inhibitors
    Publication number: 20050256174
    Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
    Type: Application
    Filed: June 10, 2005
    Publication date: November 17, 2005
    Inventors: Jill Wood, Hanno Wild, Daniel Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger Smith, Cheri Blum
  • Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
    Publication number: 20050038101
    Abstract: The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of diseases in humans and/or animals.
    Type: Application
    Filed: September 16, 2002
    Publication date: February 17, 2005
    Inventors: Jens-Kerim Erguden, Thomas Krahn, Christian Schroder, Johannes-Peter Stasch, Stefan Weigand, Hanno Wild, Michael Brands
  • Raf kinase inhibitors
    Publication number: 20010006975
    Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
    Type: Application
    Filed: January 8, 2001
    Publication date: July 5, 2001
    Applicant: BAYER CORPORATION and ONYX PHARMACEUTICALS West Haven, CT and Richmond, CA, respectively
    Inventors: Jill E. Wood, Hanno Wild, Daniel H. Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A. Smith, Cheri Blum
  • Inhibition of raf kinase activity using aryl ureas
    Patent number: 6187799
    Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: February 13, 2001
    Assignees: Onyx Pharmaceuticals, Bayer Corporation
    Inventors: Jill E Wood, Hanno Wild, Daniel H Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A. Smith, Cheri Blum
  • hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
    Patent number: 6130318
    Abstract: The present invention relates to novel hIL-4 mutant proteins, to processes for preparing them, and to their use as medicaments, in particular in overshooting, falsely regulated immune reactions and autoimmune diseases.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: October 10, 2000
    Assignee: Bayer Aktiengellschaft
    Inventors: Hanno Wild, Rudolf Hanko, Michael Dorschug, Hans-Dietrich Horlein, Jurgen Beunink, Heiner Apeler, Hermann Wehlmann, Walter Sebald
  • Heteroatom-containing benzocyclopentane-oxazolidinones
    Patent number: 6069160
    Abstract: The invention relates to heteroatom-containing benzocyclopentaneoxazolidinones, to processes for their preparation and their use as medicaments, especially as antibacterial medicaments.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: May 30, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Dieter Habich, Stephan Bartel, Bernd Riedl, Martin Ruppelt, Hanno Wild, Rainer Endermann, Klaus-Dieter Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • Heteroatom-containing cyclopentanopyridyl-oxazolidinones
    Patent number: 5869659
    Abstract: The present invention relates to heteroatom-containing cyclopentanopyridyl-oxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: January 13, 1997
    Date of Patent: February 9, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Dieter Habich, Bernd Riedl, Martin Ruppelt, Stephen Bartel, Walter Guarnieri, Hanno Wild, Rainer Endermann, Hein-Peter Kroll
  • 6-membered nitrogen-containing heteroaryl-oxazolidinones
    Patent number: 5843967
    Abstract: The invention relates to 6-membered nitrogen-containing heteroaryloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: December 1, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernd Riedl, Dieter Habich, Andreas Stolle, Hanno Wild, Rainer Endermann, Klaus Dieter Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • 5-membered heteroaryl-oxazolidinones
    Patent number: 5698574
    Abstract: The present invention relates to 5-membered heteroaryl-oxazolidinones, to processes for their preparation and to their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: July 17, 1995
    Date of Patent: December 16, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernd Riedl, Dieter Habich, Andreas Stolle, Hanno Wild, Rainer Endermann, Klaus Dieter Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • Benzofuranyl -and benzothienyloxazolidinones
    Patent number: 5684023
    Abstract: The present invention relates to benzofuranyl- and benzothienyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: July 17, 1995
    Date of Patent: November 4, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernd Riedl, Dieter Habich, Andreas Stolle, Hanno Wild, Rainer Endermann, Klaus Dieter Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • 6-membered nitrogen-containing heteroaryl-oxazolidinones
    Patent number: 5627181
    Abstract: The invention relates to 6-membered nitrogen-containing heteroaryloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: July 17, 1995
    Date of Patent: May 6, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernd Riedl, Dieter H abich, Andreas Stolle, Hanno Wild, Rainer Endermann, Klaus D. Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents
    Patent number: 5571921
    Abstract: The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretroviral agents.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 5, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Bender, Dieter H abich, Siegfried Raddatz, Wolfgang R oben, Hanno Wild, Jutta Hansen, Arnold Paessens
  • 6-thiono-5,6-dihydro-dibenz[B,E] azepin-11-one-11-oximes
    Patent number: 5545736
    Abstract: The invention relates to 6-thiono-dibenz[b,e]azepines, to a process for their preparation and to their use as inhibitors of reverse transcriptase and in particular as antiretroviral agents.
    Type: Grant
    Filed: January 9, 1995
    Date of Patent: August 13, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Roeben, Arnold Paessens, J org Petersen-von Gehr
  • Benzoxazolyl- and benzothiazolyloxazolidinones
    Patent number: 5529998
    Abstract: The invention relates to benzoxazolyl- and benzothiazolyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
    Type: Grant
    Filed: July 27, 1995
    Date of Patent: June 25, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Habich, Bernd Riedl, Martin Ruppelt, Andreas Stolle, Hanno Wild, Rainer Endermann, Klaus D. Bremm, Hein-Peter Kroll, Harald Labischinski, Klaus Schaller, Hans-Otto Werling
  • Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation
    Patent number: 5492918
    Abstract: The present invention relates to the use of substituted chromans of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, for the production of medicaments, in particular as HIV protease-inhibiting agents, new active compounds and processes for their preparation.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: February 20, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Bender, Dieter Habich, Hans-Georg Heine, Siegfried Raddatz, Wolfgang Roben, Jutta Hansen, Arnold Paessens
  • 5-oxo-dibenzo[a,d]cyclohepta-1,4-dienes
    Patent number: 5457108
    Abstract: The invention relates to substituted 5-oxo-di-benzo[a,d]cyclohepta-1,4-dienes of the formula (I) ##STR1## processes for their preparation and their use as retroviral agents.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: October 10, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Jutta Hansen, Jorg Lautz, Arnold Paessens
  • 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
    Patent number: 5416209
    Abstract: The invention relates to 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes, to processes for their preparation and to their use as inhibitors of reverse transcriptase and in particular as antiretroviral agents.
    Type: Grant
    Filed: November 18, 1992
    Date of Patent: May 16, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Roeben, Gerd Aichinger, Arnold Paessens, Jorg Peters n-von Gehr
  • Aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
    Patent number: 5385899
    Abstract: The invention relates to aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes, to processes for their preparation and to their use as antiretroviral agents.
    Type: Grant
    Filed: November 17, 1992
    Date of Patent: January 31, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Roeben, Gerd Aichinger, Arnold Paessens, Jorg Petersen-von Gehr
  • Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors
    Patent number: 5108747
    Abstract: A pharmaceutical preparation comprising an antibiotic, a pharmaceutical excipient therefor, and in addition an oxapenem-3-carboxylic acid of the formula ##STR1## or a pharmaceutically acceptable salt, ester or amide in which R.sup.1 and R.sup.2 each independently is hydrogen or a pharmaceutically acceptable group having 1 to 10 carbon atoms which is connected with the balance of the molecule via carbon-carbon single bonds, and in whichR.sup.3, R.sup.4 and R.sup.5 each independently is a pharmaceutically acceptable group having 1 to 10 carbon atoms which is connected with the balance of the molecule via carbon-carbon single bonds.
    Type: Grant
    Filed: September 27, 1989
    Date of Patent: April 28, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Rudolf Pfaendler, Karl G. Metzger, Rainer Endermann, Ingo Haller, Hanno Wild, Wolfgang Hartiwg